James Chalmers, MD

University of Dundee

Articles by James Chalmers, MD

Brensocatib Could Change the Landscape of Bronchiectasis Treatment: James Chalmers, MD

ByJulia Bonavitacola,Pearl Steinzor,James Chalmers, MD

June 2nd 2025

The landscape of treatment for bronchiectasis could change significantly with the approval of brensocatib, offering a more direct method of stemming the adverse events related to the condition, explains James Chalmers, MD, University of Dundee.

ASPEN Trial Shows Efficacy of Brensocatib in Different Dosages: James Chalmers, MD

ByJulia Bonavitacola,Pearl Steinzor,James Chalmers, MD

May 31st 2025

Different dosages of brensocatib proved effective in treating people living with bronchiectasis when studied in the ASPEN trial.

First-in-Class Brensocatib Could Help Treat Patients With Bronchiectasis: James Chalmers, MD

ByJulia Bonavitacola,Pearl Steinzor,James Chalmers, MD

May 29th 2025

The approval of brensocatib for use in patients with bronchiectasis could offer the first treatment directly addressing the roots of the condition.

James Chalmers, MD

Articles by James Chalmers, MD

Brensocatib Could Change the Landscape of Bronchiectasis Treatment: James Chalmers, MD

ASPEN Trial Shows Efficacy of Brensocatib in Different Dosages: James Chalmers, MD

First-in-Class Brensocatib Could Help Treat Patients With Bronchiectasis: James Chalmers, MD

Latest Updated Articles

Trending on AJMC

Three Years on Baricitinib Preserved Hair Regrowth in Severe Alopecia Areata

First Clinical Evidence of Gene Editing, Epigenetic Silencing of HBV cccDNA

Plastic in Personal Care Products Tied to Skin Disease and Environmental Pollution, Review Finds

First FDA-Approved Inhaled Insulin for Kids Arrives With Mounting Data: Kevin Kaiserman, MD

Delgocitinib Coverage Could Save Health Plans $88M Over 3 Years